0001587221-17-000020.txt : 20170526 0001587221-17-000020.hdr.sgml : 20170526 20170526175351 ACCESSION NUMBER: 0001587221-17-000020 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170524 FILED AS OF DATE: 20170526 DATE AS OF CHANGE: 20170526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zosano Pharma Corp CENTRAL INDEX KEY: 0001587221 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454488360 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34790 ARDENTECH COURT CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-1200 MAIL ADDRESS: STREET 1: 34790 ARDENTECH COURT CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: ZP Holdings Inc DATE OF NAME CHANGE: 20130919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WALKER JOHN PETER CENTRAL INDEX KEY: 0001213529 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36570 FILM NUMBER: 17875162 MAIL ADDRESS: STREET 1: 126 ISABELLA AVE CITY: ATHERTON STATE: CA ZIP: 94027 4/A 1 edgar.xml PRIMARY DOCUMENT X0306 4/A 2017-05-24 2017-05-25 0001587221 Zosano Pharma Corp ZSAN 0001213529 WALKER JOHN PETER C/O ZOSANO PHARMA CORPORATION 34790 ARDENTECH COURT FREMONT CA 94555 1 1 0 0 Interim CEO Common Stock 2017-05-24 4 P 0 36166 1.3425 A 169344 D Common Stock 2017-05-25 4 P 0 37550 1.3672 A 206894 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.35, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.38, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. This Amended Form 4 is being filed to revise Footnotes 1 and 2 of the original Form 4 to state that the shares were "purchased" and not "sold." This amendment corrects an administrative error. /s/ Jeffrey L. Quillen, attorney-in-fact 2017-05-26